Vai direttamente al contenuto

Oncologia

Rischi e incertezze delle emotrasfusioni

Blood transfusion and cancer surgery outcomes: a continued reason for concern. (apre una nuova finestra)

Al-Refaie WB, Parsons HM, Markin A, Abrams J, Habermann EB.

Fonte‎: Surgery 2012;152(3):344-54.

Indicizzato‎: PubMed 22938895

DOI‎: 10.1016/j.surg.2012.06.008

https://www.ncbi.nlm.nih.gov/pubmed/22938895 (apre una nuova finestra)

Perioperative blood transfusions promote pancreas cancer progression. (apre una nuova finestra)

Benson D, Barnett CC Jr.

Fonte‎: J Surg Res 2011;166(2):275-9.

Indicizzato‎: PubMed 20828757

DOI‎: 10.1016/j.jss.2010.05.059

https://www.ncbi.nlm.nih.gov/pubmed/20828757 (apre una nuova finestra)

Impact of allogeneic and autologous transfusion on immune function in patients with tumors. (apre una nuova finestra)

Guo JR, Xu F, Jin XJ, Shen HC, Liu Y, Zhang YW, Shao Y.

Fonte‎: Asian Pac J Cancer Prev 2014;15(1):467-74.

Indicizzato‎: PubMed 24528076

https://www.ncbi.nlm.nih.gov/pubmed/24528076 (apre una nuova finestra)

A cohort investigation of anaemia, treatment and the use of allogeneic blood transfusion in colorectal cancer surgery. (apre una nuova finestra)

Keeler BD, Mishra A, Stavrou CL, Beeby S, Simpson JA, Acheson AG.

Fonte‎: Ann Med Surg (Lond) 2016;6:6-11.

Indicizzato‎: PubMed 26909150

DOI‎: 10.1016/j.amsu.2015.12.052

https://www.ncbi.nlm.nih.gov/pubmed/26909150 (apre una nuova finestra)

Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. (apre una nuova finestra)

Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH.

Fonte‎: Arch Intern Med 2008;168(21):2377-81.

Indicizzato‎: PubMed 19029504

DOI‎: 10.1001/archinte.168.21.2377

https://www.ncbi.nlm.nih.gov/pubmed/19029504 (apre una nuova finestra)

Perioperative blood transfusion, age at surgery, and prognosis in a database of 526 upper gastrointestinal cancers. (apre una nuova finestra)

Kosumi K, Baba Y, Harada K, Yoshida N, Watanabe M, Baba H.

Fonte‎: Dig Surg 2015;32(6):445-53.

Indicizzato‎: PubMed 26550999

DOI‎: 10.1159/000433609

https://www.ncbi.nlm.nih.gov/pubmed/26550999 (apre una nuova finestra)

Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. (apre una nuova finestra)

Liu L, Wang Z, Jiang S, Shao B, Liu J, Zhang S, Zhou Y, Zhou Y, Zhang Y.

Fonte‎: PLoS One 2013;8(5):e64261.

Indicizzato‎: PubMed 23741309

DOI‎: 10.1371/journal.pone.0064261

https://www.ncbi.nlm.nih.gov/pubmed/23741309 (apre una nuova finestra)

Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer. (apre una nuova finestra)

Melis M, McLoughlin JM, Dean EM, Siegel EM, Weber JM, Shah N, Kelley ST, Karl RC.

Fonte‎: J Surg Res 2009;153(1):114-20.

Indicizzato‎: PubMed 19201421

DOI‎: 10.1016/j.jss.2008.06.005

https://www.ncbi.nlm.nih.gov/pubmed/19201421 (apre una nuova finestra)

How low should we go: A systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. (apre una nuova finestra)

Prescott LS, Taylor JS, Lopez-Olivo MA, Munsell MF, VonVille HM, Lairson DR, Bodurka DC.

Fonte‎: Cancer Treat Rev 2016;46:1-8.

Indicizzato‎: PubMed 27046422

DOI‎: 10.1016/j.ctrv.2016.03.010

https://www.ncbi.nlm.nih.gov/pubmed/27046422 (apre una nuova finestra)

Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases. (apre una nuova finestra)

Schiergens TS, Rentsch M, Kasparek MS, Frenes K, Jauch KW, Thasler WE.

Fonte‎: Dis Colon Rectum 2015;58(1):74-82.

Indicizzato‎: PubMed 25489697

DOI‎: 10.1097/DCR.0000000000000233

https://www.ncbi.nlm.nih.gov/pubmed/25489697 (apre una nuova finestra)